🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 11

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 11 of 20
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jun 25, 2024 at 3:28 PM#51
wendy_avl said:
If you are going to change something, change one thing and give it long enough to express itself.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

8 8VendorMark, COA_Karl, MikeFit_NJ and 5 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Jun 29, 2024 at 4:13 AM#52
wendy_avl said:
If you are going to change something, change one thing and give it long enough to express itself.

Thank you for spelling out the reasoning rather than just the conclusion.

7 7MikeNYC_runner and 4 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Jul 2, 2024 at 4:56 PM#53

Adding the clinical framing, because it changes how the question reads. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

6 6Dr.LipidDallas, alex_tucson, kevin_tulsa and 3 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
amy_econ_NJ
Member
567
2,567
May 2024
Princeton, NJ
Jul 6, 2024 at 5:37 AM#54

Old thread, but it comes up first when you search for this, so it is worth updating. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Happy to go further on any of that.

5 5gary_naperville, sean_dublin, hannah_MT and 2 others
Reply Quote Save Share Report
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Jul 9, 2024 at 6:16 PM#55
hans_munich said:
The mechanism and the magnitude are separate questions.

Adding the part of the answer the thread has not reached. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Last edited: Jul 9, 2024 at 7:16 PM
4 4nancy_portland, rick_sfbay, maria_elpaso and 1 other
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register